{"pmid":32366190,"title":"Intersectionality as a lens to the COVID-19 pandemic: implications for sexual and reproductive health in development and humanitarian contexts.","text":["Intersectionality as a lens to the COVID-19 pandemic: implications for sexual and reproductive health in development and humanitarian contexts.","Sex Reprod Health Matters","Lokot, Michelle","Avakyan, Yeva","32366190"],"journal":"Sex Reprod Health Matters","authors":["Lokot, Michelle","Avakyan, Yeva"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32366190","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1080/26410397.2020.1764748","keywords":["covid-19","gender","humanitarian","intersectionality","power","sexual and reproductive health"],"topics":["Prevention"],"weight":1,"_version_":1666138496235995137,"score":9.490897,"similar":[{"pmid":32326943,"pmcid":"PMC7179791","title":"Sexual and reproductive health (SRH): a key issue in the emergency response to the coronavirus disease (COVID- 19) outbreak.","text":["Sexual and reproductive health (SRH): a key issue in the emergency response to the coronavirus disease (COVID- 19) outbreak.","The novel coronavirus disease (COVID-19) outbreak was first declared in China in December 2019, and WHO declared the pandemic on 11 March 2020. A fast-rising number of confirmed cases has been observed in all continents, with Europe at the epicentre of the outbreak at this moment.Sexual and reproductive health (SRH) and rights is a significant public health issue during the epidemics. The novel coronavirus (SARS-CoV-2) is new to humans, and only limited scientific evidence is available to identify the impact of the disease COVID-19 on SRH, including clinical presentation and outcomes of the infection during pregnancy, or for persons with STI/HIV-related immunosuppression. Beyond the clinical scope of SRH, we should not neglect the impacts at the health system level and disruptions or interruptions in regular provision of SRH services, such as pre- and postnatal checks, safe abortion, contraception, HIV/AIDS and sexually transmitted infections. Furthermore, other aspects merit attention such as the potential increase of gender-based violence and domestic abuse, and effects of stigma and discrimination associated with COVID-19 and their effects on SRH clients and health care providers. Therefore, there is an urgent need for the scientific community to generate sound clinical, epidemiological, and psycho-social behavioral links between COVID-19 and SRH and rights outcomes.","Reprod Health","Tang, Kun","Gaoshan, Junjian","Ahonsi, Babatunde","32326943"],"abstract":["The novel coronavirus disease (COVID-19) outbreak was first declared in China in December 2019, and WHO declared the pandemic on 11 March 2020. A fast-rising number of confirmed cases has been observed in all continents, with Europe at the epicentre of the outbreak at this moment.Sexual and reproductive health (SRH) and rights is a significant public health issue during the epidemics. The novel coronavirus (SARS-CoV-2) is new to humans, and only limited scientific evidence is available to identify the impact of the disease COVID-19 on SRH, including clinical presentation and outcomes of the infection during pregnancy, or for persons with STI/HIV-related immunosuppression. Beyond the clinical scope of SRH, we should not neglect the impacts at the health system level and disruptions or interruptions in regular provision of SRH services, such as pre- and postnatal checks, safe abortion, contraception, HIV/AIDS and sexually transmitted infections. Furthermore, other aspects merit attention such as the potential increase of gender-based violence and domestic abuse, and effects of stigma and discrimination associated with COVID-19 and their effects on SRH clients and health care providers. Therefore, there is an urgent need for the scientific community to generate sound clinical, epidemiological, and psycho-social behavioral links between COVID-19 and SRH and rights outcomes."],"journal":"Reprod Health","authors":["Tang, Kun","Gaoshan, Junjian","Ahonsi, Babatunde"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32326943","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1186/s12978-020-0900-9","keywords":["covid-19","outbreak","pandemic","sexual and reproductive health"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138494546739200,"score":109.80899},{"pmid":32479893,"title":"Ivermectin: repurposing a multipurpose drug for Venezuela's humanitarian crisis.","text":["Ivermectin: repurposing a multipurpose drug for Venezuela's humanitarian crisis.","For decades, Ivermectin (IVM) has been recognized as a robust antiparasitic drug with excellent tolerance and safety profiles. Historically it has been used as the drug of choice for onchocerciasis and lymphatic filariasis global elimination programs. IVM is also a standard treatment against intestinal helminths and ectoparasites given its action as an oral insecticide. The current humanitarian crisis in Venezuela is a regional public health threat that requires immediate action. Venezuela's public health system has now crumbled due to a 70% shortage of medicines in public hospitals, low vaccination campaigns, and the massive exodus of medical personnel. Herein we discuss the repurposing of IVM to attenuate the burden imposed by the most prevalent neglected tropical diseases (NTDs) in Venezuela including soil-transmitted helminths, ectoparasites and, possibly, vector-borne diseases such as malaria. Additionally, novel experimental evidence has shown that IVM is active and efficacious against Chagas disease, Leishmaniases, arboviruses, and SARS-CoV-2 in vitro. In crisis-hit Venezuela, all of the aforementioned infectious diseases are public health emergencies that have been long ignored and that also require immediate attention. IVM's versatile nature could serve as a powerful tool to tackle the multiple overlapping endemic and emergent diseases that affect Venezuela today. The repurposing of this multipurpose drug would be without a doubt a timely therapeutical approach to help mitigate the tremendous burden of NTDs nationwide.","Int J Antimicrob Agents","Perez-Garcia, Luis A","Mejias-Carpio, Isis E","Delgado-Noguera, Lourdes A","Manzanarez-Motezuma, Jean P","Escalona-Rodriguez, Maria A","Sordillo, Emilia M","Mogollon-Rodriguez, Euler A","Hernandez-Pereira, Carlos E","Marquez-Colmenarez, Marilianna C","Paniz-Mondolfi, Alberto E","32479893"],"abstract":["For decades, Ivermectin (IVM) has been recognized as a robust antiparasitic drug with excellent tolerance and safety profiles. Historically it has been used as the drug of choice for onchocerciasis and lymphatic filariasis global elimination programs. IVM is also a standard treatment against intestinal helminths and ectoparasites given its action as an oral insecticide. The current humanitarian crisis in Venezuela is a regional public health threat that requires immediate action. Venezuela's public health system has now crumbled due to a 70% shortage of medicines in public hospitals, low vaccination campaigns, and the massive exodus of medical personnel. Herein we discuss the repurposing of IVM to attenuate the burden imposed by the most prevalent neglected tropical diseases (NTDs) in Venezuela including soil-transmitted helminths, ectoparasites and, possibly, vector-borne diseases such as malaria. Additionally, novel experimental evidence has shown that IVM is active and efficacious against Chagas disease, Leishmaniases, arboviruses, and SARS-CoV-2 in vitro. In crisis-hit Venezuela, all of the aforementioned infectious diseases are public health emergencies that have been long ignored and that also require immediate attention. IVM's versatile nature could serve as a powerful tool to tackle the multiple overlapping endemic and emergent diseases that affect Venezuela today. The repurposing of this multipurpose drug would be without a doubt a timely therapeutical approach to help mitigate the tremendous burden of NTDs nationwide."],"journal":"Int J Antimicrob Agents","authors":["Perez-Garcia, Luis A","Mejias-Carpio, Isis E","Delgado-Noguera, Lourdes A","Manzanarez-Motezuma, Jean P","Escalona-Rodriguez, Maria A","Sordillo, Emilia M","Mogollon-Rodriguez, Euler A","Hernandez-Pereira, Carlos E","Marquez-Colmenarez, Marilianna C","Paniz-Mondolfi, Alberto E"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32479893","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.ijantimicag.2020.106037","keywords":["ivermectin","venezuela","crisis","endemic","epidemic","humanitarian","multipurpose"],"locations":["Venezuela","Venezuela","Venezuela","Venezuela","Venezuela","Venezuela"],"countries":["Venezuela, Bolivarian Republic of"],"countries_codes":["VEN|Venezuela, Bolivarian Republic of"],"topics":["Treatment"],"weight":1,"_version_":1668437835180408832,"score":96.562675},{"pmid":32404178,"title":"Prioritizing vulnerable populations and women on the frontlines: COVID-19 in humanitarian contexts.","text":["Prioritizing vulnerable populations and women on the frontlines: COVID-19 in humanitarian contexts.","The COVID-19 outbreak has been declared a global pandemic and cases are being reported among displaced populations that are particularly vulnerable to infection. Humanitarian workers on the frontlines of the response are working in some of the most challenging contexts and also face elevated risk of contracting COVID-19 and potential stigmatization or violence in the community. Women humanitarians may be at even greater risk, but their protection is dependent on organization-specific policies and procedures. Without gender balance in leadership positions, the specific needs of women may not be prioritized and women may not be included in decision-making or design of responses. Ensuring gender equitable access to personal protective equipment and information is imperative, but additional measures must be put into place to ensure the protection of women on the frontlines while reducing COVID-19 deaths and adverse health effects among displaced populations.","Int J Equity Health","Sharma, Vandana","Scott, Jennifer","Kelly, Jocelyn","VanRooyen, Michael J","32404178"],"abstract":["The COVID-19 outbreak has been declared a global pandemic and cases are being reported among displaced populations that are particularly vulnerable to infection. Humanitarian workers on the frontlines of the response are working in some of the most challenging contexts and also face elevated risk of contracting COVID-19 and potential stigmatization or violence in the community. Women humanitarians may be at even greater risk, but their protection is dependent on organization-specific policies and procedures. Without gender balance in leadership positions, the specific needs of women may not be prioritized and women may not be included in decision-making or design of responses. Ensuring gender equitable access to personal protective equipment and information is imperative, but additional measures must be put into place to ensure the protection of women on the frontlines while reducing COVID-19 deaths and adverse health effects among displaced populations."],"journal":"Int J Equity Health","authors":["Sharma, Vandana","Scott, Jennifer","Kelly, Jocelyn","VanRooyen, Michael J"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404178","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1186/s12939-020-01186-4","keywords":["covid-19","displaced populations","essential workers","gender","gender bias","humanitarian contexts","humanitarian organizations","women"],"topics":["Prevention"],"weight":1,"_version_":1666802845265952769,"score":94.23982},{"pmid":32436422,"title":"Men and COVID-19: Adding a gender lens.","text":["Men and COVID-19: Adding a gender lens.","In this commentary, the authors point out that there are important gender determinants to both men's and women's vulnerabilities to COVID-19, and call on the global health community to unpack and address these early in the COVID-19 pandemic response. They point to best practices and tools from two decades of engaging men in research and programming in the sexual and reproductive health field.","Glob Public Health","Betron, Myra","Gottert, Ann","Pulerwitz, Julie","Shattuck, Dominick","Stevanovic-Fenn, Natacha","32436422"],"abstract":["In this commentary, the authors point out that there are important gender determinants to both men's and women's vulnerabilities to COVID-19, and call on the global health community to unpack and address these early in the COVID-19 pandemic response. They point to best practices and tools from two decades of engaging men in research and programming in the sexual and reproductive health field."],"journal":"Glob Public Health","authors":["Betron, Myra","Gottert, Ann","Pulerwitz, Julie","Shattuck, Dominick","Stevanovic-Fenn, Natacha"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32436422","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1080/17441692.2020.1769702","keywords":["covid-19","gender","infectious diseases","masculinities","men's health"],"topics":["Prevention"],"weight":1,"_version_":1667521393530503169,"score":82.092766},{"pmid":32330429,"pmcid":"PMC7173831","title":"Not a luxury: a call to maintain sexual and reproductive health in humanitarian and fragile settings during the COVID-19 pandemic.","text":["Not a luxury: a call to maintain sexual and reproductive health in humanitarian and fragile settings during the COVID-19 pandemic.","Lancet Glob Health","Tran, Nguyen Toan","Tappis, Hannah","Spilotros, Nathaly","Krause, Sandra","Knaster, Sarah","32330429"],"journal":"Lancet Glob Health","authors":["Tran, Nguyen Toan","Tappis, Hannah","Spilotros, Nathaly","Krause, Sandra","Knaster, Sarah"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330429","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/S2214-109X(20)30190-X","topics":["Prevention"],"weight":1,"_version_":1666138494623285249,"score":79.05414}]}